Study Design Select Study Design * Qualitative Quantitative Mixed Methods Study Overview Study Title * Short & accessible Plain Language Summary * Max 300 words Lead Researcher Name * Other Researchers / Team (optional) Institution / Organization * Ethics Approval Number (optional but encouraged) Recruitment Start Date * MM DD YYYY Recruitment End Date Leave Blank if Ongoing MM DD YYYY Trial Phase * Phase 1 Phase 2 Phase 3 Observational Pilot Case Study Substance Focus * Psilocybin MDMA Ketamine Ayahuasca Therapeutic Model Used * IFS CBT Somatic Traditional Ceremony Is this an RCT? * Yes No Follow-up Psychedelic Dosing Arm Included? * Yes No Participant Eligibility & Demographics Who Can Participate? * Plain language inclusion criteria Exclusion Criteria Number of Participants Needed * Location of Participants * Online Australia-wide State-based International Preferred Participant Demographics * First Nations LGBTQIA+ CALD Youth Veterans Neurodivergent Other Participation Details Type of Participation * Interview Focus Group Survey Creative/Arts-Based Diary Method Other Time Commitment * Compensation / Reimbursement * Format * Online In-Person Hybrid Phone Technology or Tools Needed * Consent Process Summary * Access & Contact Contact Email * Phone Number (###) ### #### Sign-Up / EOI Link * (Google Form, REDCap, etc.) http:// Website or Social Media Link (optional) http:// Safety, Accessibility & Cultural Considerations Accessibility Information Interpreter available ND-friendly spaces Other Cultural Safety Considerations Trauma-informed Queer-inclusive Other Confidentiality & Privacy Statement * Filtering Tags (for Public Directory) Study Focus / Topic PAP Integration Spiritual Crisis End-of-Life Neurodiversity Group Healing Other Target Population * First Nations Gender Diverse Clinicians Veterans Chronic Pain Refugees Other Urgency Level * Seeking Participants Now Ongoing Expression of Interest Only Study Methodology Type * IPA Narrative Grounded Theory Heuristic PAR Arts-Based Somatic Indigenous Mixed (Optional): For Clinical Trials or Institutional Submissions Ethics Committee Details Name & ID Funding Body / Sponsor (if any) Trial Location In-Person Virtual Trial Start Date MM DD YYYY Trial End Date MM DD YYYY Link to Official Trial Page http:// Consent to Feature Publicly Yes, publish this study in the public database No Thank you!
